Discovery of Novel Human Breast Cancer MicroRNAs from Deep Sequencing
Author Information
Author(s): Ryu Seongho, Joshi Natasha, McDonnell Kevin, Woo Jongchan, Choi Hyejin, Gao Dingcheng, McCombie William R., Mittal Vivek
Primary Institution: Weill Cornell Medical College of Cornell University
Hypothesis
Can deep sequencing technology identify novel microRNAs in human breast cancer cell lines?
Conclusion
The study successfully identified 189 candidate novel microRNAs in human breast cancer cell lines using deep sequencing.
Supporting Evidence
- The study identified 189 candidate novel microRNAs in human breast cancer cell lines.
- The analysis of pri-microRNA secondary structure was shown to predict bona fide miRNAs with approximately 90% accuracy.
- Experimental validation confirmed that only some of the predicted candidates were expressed as mature miRNAs.
Takeaway
Scientists found new tiny molecules called microRNAs that might help us understand breast cancer better by using a special sequencing technique.
Methodology
Deep sequencing technology was used to analyze RNA from breast cancer cell lines, identifying novel microRNAs based on their secondary structures.
Limitations
The sensitivity of northern blotting may not be sufficient to detect lowly expressed miRNAs.
Participant Demographics
Human breast cancer cell lines MCF10A (nontumorigenic), MCF7 (tumorigenic, nonmetastatic), and MDA-MB-231 (tumorigenic, metastatic).
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website